Mind-bending, mind–“mending”? The effect of psychedelics on flexible cognition, and underlying neural mechanisms

(S1.2) Alexander Shulgin Research Institute: Chemistry for Consciousness

(S1.3) The development of novel non-hallucinogenic drugs based on known psychedelics

(S1.5) Panel discussion post-presentation

Toward “next generation” ketamine treatment: from new insights into the neurobiology of depression to strategies to optimize ketamine efficacy

The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder

Panel discussion on psilocybin therapy for cancer patients and palliative care

Telemedicine models for supporting psychedelic therapy

The biological antidepressant effects of Ayahuasca

The neuroscience of DMT: Past, present, and beyond